```html
<div class="section" id="section-29">
<p>Fu Yu's operating performance over the past 24 months presents a mixed picture.  Significant revenue growth, driven by increased sales in Singapore and Malaysia, particularly within the medical and consumer segments, contrasts with persistent profitability concerns.  The company's diversification and improved operational efficiency are evident, but the sustainability of this growth, especially given the Chinese market decline, requires further scrutiny. This analysis focuses on three key operating metrics.</p>

<h3>1. Revenue Growth by Geographic Segment:</h3>

<p><strong>Definition and Relevance:</strong> This metric assesses revenue performance across key geographic segments (Singapore, Malaysia, China).  It reveals market penetration, regional diversification, and the impact of regional economic conditions.</p>

<p><strong>Historical Data (Past 24 Months):</strong></p>

<ul>
    <li><strong>FY2023:</strong>
        <ul>
            <li>Singapore: S$38.2 million [SOURCE: Fu Yu 24 AR_m.md, page 8]</li>
            <li>Malaysia: S$29.3 million [SOURCE: Fu Yu 24 AR_m.md, page 8]</li>
            <li>China: S$36.4 million [SOURCE: Fu Yu 24 AR_m.md, page 8]</li>
        </ul>
    </li>
    <li><strong>1H2024:</strong>
        <ul>
            <li>Singapore: S$21.0 million [SOURCE: Fuyu Pres H124_m.md, page 5]</li>
            <li>Malaysia: S$17.8 million [SOURCE: Fuyu Pres H124_m.md, page 5]</li>
            <li>China: S$16.0 million [SOURCE: Fuyu Pres H124_m.md, page 5]</li>
        </ul>
    </li>
    <li><strong>FY2024:</strong>
        <ul>
            <li>Singapore: S$46.2 million [SOURCE: Fu Yu 24 AR_m.md, page 4, 8]</li>
            <li>Malaysia: S$36.6 million [SOURCE: Fu Yu 24 AR_m.md, page 4, 8]</li>
            <li>China: S$32.1 million [SOURCE: Fu Yu 24 AR_m.md, page 4, 8]</li>
        </ul>
    </li>
</ul>

<p><strong>Benchmarking and Outperformance/Underperformance:</strong> Benchmarking requires competitor data, which is not provided.</p>

<p><strong>Drivers of Performance:</strong> Strong growth in Singapore and Malaysia is attributed to higher sales in the medical and consumer segments [SOURCE: Fu Yu 24 AR_m.md, page 8]. The decline in China is due to slower business activities [SOURCE: Fu Yu 24 AR_m.md, page 8].</p>

<p><strong>Sustainability:</strong> Sustainability depends on maintaining growth in Singapore and Malaysia and addressing Chinese market challenges. Further analysis is needed to understand the Chinese market decline.</p>

<p><strong>Financial Impact:</strong> Strong performance in Singapore and Malaysia contributed to the 10.5% revenue growth in FY2024 [SOURCE: Fu Yu 24 AR_m.md, page 4]. The decline in China partially offset this growth.</p>

<p><strong>Due Diligence Questions:</strong></p>
<ol>
    <li>What strategies address the Chinese market decline, and what is the projected recovery timeline?</li>
    <li>Can Singapore and Malaysia's growth trajectory be sustained, given current market dynamics and competition?</li>
</ol>


<h3>2. Gross Profit Margin:</h3>

<p><strong>Definition and Relevance:</strong> Gross Profit Margin (GPM) measures product profitability after deducting direct production costs.  It reflects pricing strategies, cost efficiency, and product competitiveness.</p>

<p><strong>Historical Data (Past 24 Months):</strong></p>

<ul>
    <li><strong>FY2023:</strong> 11.7% [SOURCE: Fu Yu 24 AR_m.md, page 4]</li>
    <li><strong>1H2024:</strong> 6.7% [SOURCE: Fuyu Pres H124_m.md, page 6]</li>
    <li><strong>FY2024:</strong> 13.5% (manufacturing segment); 8.9% (Group-wide) [SOURCE: Fu Yu 24 AR_m.md, page 4, 7]</li>
</ul>

<p><strong>Benchmarking and Outperformance/Underperformance:</strong> Benchmarking requires competitor data, which is not provided.</p>

<p><strong>Drivers of Performance:</strong> The FY2024 GPM improvement is attributed to increased efficiency and improved pricing strategies [SOURCE: Implicit from the increase in GPM despite the change in revenue mix, which is noted in Fuyu Pres H124_m.md page 6]. The lower 1H2024 GPM is explained by a change in revenue mix [SOURCE: Fuyu Pres H124_m.md, page 6].</p>

<p><strong>Sustainability:</strong> Margin improvement sustainability hinges on maintaining cost efficiencies and pricing power, especially given the changing revenue mix impacting 1H2024 margins.</p>

<p><strong>Financial Impact:</strong> Increased FY2024 GPM (compared to FY2023) significantly contributed to the substantial increase in gross profit [SOURCE: Fu Yu 24 AR_m.md, page 4, 7].</p>

<p><strong>Due Diligence Questions:</strong></p>
<ol>
    <li>What cost reduction initiatives improved gross profit margins, and how sustainable are these initiatives?</li>
    <li>What are the projected gross profit margins for the next 12-24 months, considering the expected revenue mix and potential changes in input costs?</li>
</ol>


<h3>3. Operating Cash Flow:</h3>

<p><strong>Definition and Relevance:</strong> Operating cash flow is cash generated from core business operations. It assesses financial health and the ability to fund operations and investments.</p>

<p><strong>Historical Data (Past 24 Months):</strong></p>

<ul>
    <li><strong>FY2023:</strong> Net operating cash outflow of S$4.5 million [SOURCE: Fu Yu 24 AR_m.md, page 4]</li>
    <li><strong>FY2024:</strong> Net operating cash inflow of S$3.6 million [SOURCE: Fu Yu 24 AR_m.md, page 4]</li>
    <li><strong>1H2024:</strong> Data not explicitly provided for 1H2024 operating cash flow.</li>
</ul>

<p><strong>Benchmarking and Outperformance/Underperformance:</strong> Benchmarking requires competitor data, which is unavailable.</p>

<p><strong>Drivers of Performance:</strong> The turnaround from cash outflow to inflow in FY2024 suggests improved operational efficiency and working capital management [SOURCE: Implicit from the change in net cash flow figures for FY2023 and FY2024].</p>

<p><strong>Sustainability:</strong> Sustainable positive operating cash flow hinges on consistent revenue generation, effective cost management, and efficient working capital management.</p>

<p><strong>Financial Impact:</strong> Positive FY2024 operating cash flow significantly improved the company's liquidity position [SOURCE: Fu Yu 24 AR_m.md, page 4].</p>

<p><strong>Due Diligence Questions:</strong></p>
<ol>
    <li>What actions improved operating cash flow, and what are the projections for the coming years?</li>
    <li>What is the company's working capital management strategy, and how effective is it in optimizing cash flow?</li>
</ol>

<p>This analysis highlights significant growth in Singapore and Malaysia, improved profitability reflected in GPM, and a positive turnaround in operating cash flow. However, further due diligence is needed to assess the sustainability of these trends, particularly regarding the Chinese market and potential impacts of changing market conditions and competition. Detailed competitive benchmarking information would significantly strengthen this analysis.</p>
</div>
```
